Combination of HBV immunotherapy with shrna-mediated PD-1/PDL checkpoint inhibition for treatment of chronic HBV
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210762
- Recipient
-
Carogen Corp UEI JNMNVKEUU2Y3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $5,515,484
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- New Haven, CT 06518, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $5,515,484 |
Quick answers
Who received award W81XWH2210762?
W81XWH2210762 was awarded to Carogen Corp by Defense Health Agency (Department of Defense) on September 15, 2022.
How much is award W81XWH2210762 worth?
$5,515,484 has been obligated on W81XWH2210762.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award